Recor Medical's renal denervation system wins FDA panel nod, J&J finalizes Kenvue split off

Masimo this week announced the launch of its Stork home baby monitoring system. Fast Five hosts Sean Whooley and Danielle Kirsh explain how the system works and how it fits in with the flagship products already with the company. Home hemodialysis is on the rise. Fresenius Medical Care recently received FDA 510(k) clearance for its Versi HD with GuideMe software for its chronic home hemodialysis system. Find out when the technology will become available and how executives envision it for use in the home in today's episode. Diabetes care devices are consistently innovating, and Welldoc's continuous glucose monitoring is having an exceptional month. Just a week after it received its tenth FDA clearance, Welldoc has received its 11th FDA clearance for its BlueStar digital diabetes management platform. Whooley details what makes this clearance unique and what the clearance allows the company to do. Johnson & Johnson is placing more focus on its MedTech and Pharmaceutical division by splitting off its Kenvue consumer health business. The Fast Five hosts share the results of the split off and what executives are saying. Renal denervation is a hot topic in medtech right now with varying opinions on its success. This week, an FDA panel voted unanimously in favor of the safety and efficacy of Recor Medical's Paradise ultrasound renal denervation system. Find out what data was included in the PMA submission and what executives are saying. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.